Balyasny Asset Management LLC Bio Rad Laboratories, Inc. Transaction History

Balyasny Asset Management LLC

$58 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$269.37 - $365.04 $4.24 Million - $5.74 Million	15,730 New	15,730 $5.08 Million
Q4 2022 Feb 14, 2023	BUY	$351.71 - $456.01 $23.6 Million - $30.6 Million	67,043 New	67,043 $28.2 Million
Q2 2022 Aug 15, 2022	SELL	$463.67 - $597.16 $13.2 Million - $17 Million	-28,464 Reduced 34.37%	54,343 $26.9 Million
Q1 2022 May 16, 2022	BUY	$524.57 - $735.42 $16.8 Million - $23.6 Million	32,082 Added 63.25%	82,807 $46.6 Million
Q4 2021 Feb 14, 2022	BUY	$708.84 - $794.68 $146,729 - $164,498	207 Added 0.41%	50,725 $38.3 Million
Q2 2021 Aug 16, 2021	BUY	$576.64 - $649.04 $29.1 Million - $32.8 Million	50,518 New	50,518 $32.5 Million
Q1 2021 May 17, 2021	SELL	$547.01 - $662.35 $10.7 Million - $12.9 Million	-19,522 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$510.68 - $643.45 $5.94 Million - $7.49 Million	11,634 Added 147.49%	19,522 $11.4 Million
Q3 2020 Nov 16, 2020	SELL	$454.43 - $535.6 $8.72 Million - $10.3 Million	-19,194 Reduced 70.87%	7,888 $4.07 Million
Q2 2020 Aug 14, 2020	BUY	$334.87 - $493.06 $9.07 Million - $13.4 Million	27,082 New	27,082 $12.2 Million
Q4 2018 Feb 14, 2019	SELL	$220.1 - $309.0 $1.97 Million - $2.77 Million	-8,956 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$289.28 - $326.15 $7.27 Million - $8.2 Million	-25,133 Reduced 73.73%	8,956 $2.8 Million
Q2 2018 Aug 14, 2018	SELL	$244.1 - $303.88 $2.03 Million - $2.53 Million	-8,324 Reduced 19.63%	34,089 $9.84 Million
Q1 2018 May 15, 2018	BUY	$233.97 - $274.11 $9.68 Million - $11.3 Million	41,355 Added 3908.79%	42,413 $10.6 Million
Q4 2017 Feb 14, 2018	BUY	$216.94 - $271.3 $229,522 - $287,035	1,058	1,058 $253,000

Others Institutions Holding BIO

# of Institutions

458

Shares Held

18.2M

Call Options Held

19.5K

Put Options Held

13.9K

View Full List

About BIO-RAD LABORATORIES, INC.

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.42B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

More about BIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Account